Reversing oral anticoagulants with a focus on Andexanet Alfa
58:43
DOACs in extremes of body weight
56:16
VTE and Movement
1:00:02
Innovative modes for anticoagulation and VTE care
1:14:16
DOACs in cancer associated thrombosis: Sub-group challenges and considerations
1:14:10
New Research in VTE
43:22
The PERIOD Study
1:00:02
Thrombosis and Mens' Health
1:00:14